Metabolon Extends Biochemical Understanding of ALS

Metabolon, a diagnostics and services company based in Research Triangle Park, North Carolina, has pioneered a global metabolomics effort to profile the biochemical changes underlying ALS and has recently published its findings. Metabolon expects to discern metabolic signatures of ALS that could be used to develop diagnostic assays and serve as potential targets for drug development.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail